AI In Blood Pressure Monitoring Enters Hypergrowth Phase With 30% CAGR Through 2035
| Response Method | Detection Time | Data Source |
| AI System | 2 minutes | BP Genie Clinical Trial (2024) |
| Clinicians | 1440 minutes (24 hours) | Hospital Audit Logs (2023) |
AI systems can detect clinical issues within minutes, while traditional workflows may take up to a full day. This highlights how automation can significantly accelerate early identification and decision-making in healthcare settings.
What are the Prominent Drivers in the AI in Blood Pressure Monitoring Market?
The market is driven by the rising global burden of hypertension, growing adoption of wearable and remote monitoring devices, and demand for continuous, cuffless measurement. Advances in AI algorithms improve accuracy and early risk detection. Increasing focus on preventive healthcare, integration with digital health platforms, telemedicine growth, and greater awareness of home-based monitoring solutions are further accelerating market expansion.
You can place an order or ask any questions, please feel free to contact us at ...What are the Substantial Trends in the AI in Blood Pressure Monitoring Market?
- In November 2025, Omron Healthcare entered into an MoU with Sky Labs to expand their collaboration and bring CART BP, a cuffless blood pressure monitoring solution, to the consumer market, strengthening their presence in AI-enabled, non-invasive blood pressure monitoring technologies. In February 2025, NowPatient partnered with Lifelight to develop a smartphone-based blood pressure measurement platform. The collaboration integrates NowPatient's virtual care ecosystem with Lifelight's clinically validated technology to enable accurate, accessible blood pressure monitoring through mobile devices.
Distribution of Blood Pressure Levels Among Canadian Adults (2016–2019)
Most young adults (20–39) have normal blood pressure, but the prevalence of hypertension increases significantly with age. Adults aged 60–79 show the highest proportion of Stage 2 hypertension or diagnosed cases, indicating a strong age-related risk trend.
What is the Emerging Challenge in the AI in Blood Pressure Monitoring Market?
The market faces challenges related to data accuracy across diverse populations, limited clinical validation of cuffless technologies, and regulatory approval complexities. Variability in smartphone sensors and wearables can impact reliability. Data privacy and cybersecurity concerns, integration with existing healthcare systems, and user adherence also pose barriers. Additionally, a lack of standardized validation protocols and clinician trust may slow widespread adoption.
Regional Analysis
What Made North America Dominant in the AI in Blood Pressure Monitoring Market in 2025?
North America dominated the market in 2025 due to high adoption of digital health technologies, widespread use of widespread use of werables, and strong healthcare IT
In the U.S., the increasing prevalence of hypertension drives the adoption of AI-powered blood pressure monitoring solutions in clinical and home settings. Integration with telehealth
How did the Asia Pacific Expand At the Fastest Pace in the Market in 2025?
The Asia Pacific expanded at the fastest pace in the AI in blood pressure monitoring market in 2025 due to rising hypertension prevalence, rapid adoption of smartphones and wearables, and increasing digital health investments. Growing awareness of preventive healthcare, expanding telemedicine services, and government initiatives supporting AI-driven healthcare solutions accelerated adoption. Additionally, cost-effective technologies, a large patient population, and improving healthcare infrastructure encouraged faster deployment of AI-enabled blood pressure monitoring across emerging and developed economies in the region.
In China, the government's emphasis on smart healthcare and an aging population spur the development of AI-enhanced blood pressure monitoring. Widespread mobile usage, investment in digital health startups, partnerships between tech firms and hospitals, and supportive regulatory frameworks foster scalable innovation outcomes for patients.
Get the latest insights on life science industry segmentation with our Annual Membership:By Device Type Insights
How did the Wearable Devices Segment Dominate the AI in Blood Pressure Monitoring Market in 2025?
The wearable devices segment dominated the market un blood pressure monitoring market in 2025 due to widespread adoption of smartwatches. AI-enabled wearable provider offers convenient, cuffless measurements, seamless smartphone integration, and personalized health insights. Growing consumer focus on strong supportive care, rising chronic disease management needs, and strong support from tech companies and healthcare providers further strengthened demand for wearable-based blood pressure monitoring solutions.
The cuffless solutions segment is expected to grow at the fastest CAGR due to increasing demand for continuous, non-invasive blood pressure monitoring. These solutions enhance user comfort, support real-time data collection, and enable long-term health tracking. Advancements in AI algorithms, sensor technologies, and smartphone-based measurements are improving accuracy. Growing adoption in remote patient monitoring, telehealth, and preventive care is further accelerating the uptake of cuffless blood pressure monitoring solutions.
By Technology Insights
Why the Machine Learning Dominated the AI in Blood Pressure Monitoring Market?
The machine learning segment dominated the market due to its ability to analyze large volumes of physiological data and improve measurement accuracy over time. ML algorithms adapt to individual user patterns, enabling personalized blood pressure estimation and early risk detection. Their scalability, compatibility with wearables and smartphones, and effectiveness in real-time data processing made machine learning the most widely adopted technology across consumer and clinical monitoring solutions.
The computer vision techniques segment is expected to grow at the fastest CAGR as camera-based blood pressure measurement gains traction. These techniques enable contactless monitoring using facial imaging and PPG signals captured via smartphones, improving accessibility and user convenience. Advancements in AI accuracy, increasing smartphone penetration, and growing demand for remote, at-home health monitoring solutions are accelerating the adoption of computer vision-based blood pressure technologies during the forecast period.
By Delivery Mode Insights
How did the On-device AI Segment Dominate the AI in Blood Pressure Monitoring Market in 2025?
The on-device AI segment dominated the market in 2025 due to its ability to deliver real-time analysis without relying on cloud connectivity. This approach enhances data privacy, reduces latency, and enables continuous monitoring on wearables and smartphones. Improved edge-AI processing power, lower energy consumption, and growing demand for secure, offline health monitoring solutions further supported widespread adoption of on-device AT technologies.
The cloud-based AI segment is expected to grow at the fastest CAGR due to its ability to process large-scale health data and support advanced analytics. Cloud platforms enable continuous algorithm updates, population-level insights, and seamless integration with telehealth systems. Growing adoption of remote patient monitoring, scalability advantages, and increasing use of AI-driven clinical decision support tools are accelerating demand for cloud-based AI solutions in blood pressure monitoring.
By Application Insights
How did the Hypertension Management Segment Dominate the AI in Blood Pressure Monitoring Market in 2025?
The hypertension management segment dominated the market in 2025 due to the high global prevalence of hypertension and the need for continuous, long-term monitoring. AI-enabled solutions support early detection, personalized treatment adjustments, and improved patient adherence. Integration with wearables and remote patient adherence. Integration with wearables and remote care platforms allowed clinicians to track trends in real time, reduce complications, and optimize therapy outcomes, driving widespread adoption for hypertension-focused applications.
The remote patient monitoring segment is expected to grow at the fastest CAGR due to increasing demand for at-home care and continuous real-time data transmission, early risk alerts, and proactive intervention. Expansion of telemedicine, rising chronic disease burden, and healthcare systems' focus on reducing hospital visits and costs are accelerating the adoption of remote monitoring solutions during the forecast period.
By End-User Insights
Why the Hospitals & Acute Care Segment Dominated the AI in Blood Pressure Monitoring Market?
The hospitals & acute care segment dominated the market due to the high volume of patients requiring continuous and accurate vital sign monitoring. Hospitals adopted AI-enabled systems to improve clinical decision-making, detect complications early, and enhance workflow efficiency. Strong investment in digital health infrastructure, availability of skilled professionals, and integration with electronic health records
The homecare settings/patient (consumers) segment is expected to grow at the fastest CAGR due to rising health awareness, increasing adoption of wearable devices, and demand for convenient, at-home monitoring. AI-enabled solutions allow users to track blood pressure in real time, receive personalized insights, and share data with healthcare providers. Growth in telemedicine, preventive care initiatives, and affordable digital health technologies is further driving adoption among consumers.
Become a valued research partner with us -What are the Recent Developments in the AI in Blood Pressure Monitoring Market
- In May 2025, Niloufer Hospital introduced AmruthSwasthBharath, an AI-powered diagnostic device for non-invasive blood testing. Using remote PPG technology, it delivers results in under a minute and measures key vitals, including blood pressure, heart rate, SpO2, respiration rate, and hemoglobin A1c, directly through smartphones, enabling fast and convenient health monitoring. In April 2025, BD launched the HemoSphere Alta platform, an AI-powered hemodynamic monitoring system. The platform helps clinicians manage blood pressure fluctuations and optimize circulation in critical care. Features like the Cerebral Autoregulation Index and Acumen Hypotension Prediction Index provide advanced insights, supporting better patient management and improved clinical outcomes.
Key Players List
- Withings Aktiia SA Biospectal SA Valencell, INC. Biofourmis Edwards Lifesciences Corporation (now BD) Hello Heart FaceHeart Corporation Shen AI Huawei Technologies Co., Ltd.
Browse More Insights of Towards Healthcare:
The global blood pressure monitoring device market
The global blood pressure measuring devices market
The global ambulatory blood pressure monitoring device market
The global outpatient blood pressure monitoring equipment market
The global bilirubin blood test market
The global human blood products market
The global blood-brain barrier market
The global artificial blood substitute market
The cord blood banking services market
The global blood bank & plasma freezer market
Segments Covered in the Report
By Device Type
- Wearable Devices Smartwatches Fitness Bands Patch Sensors Smart Rings Cuffless Solutions Cuff-based Devices
By Technology
- Machine Learning Algorithms Deep Learning Supervised Unsupervised Others Computer Vision Techniques Natural Language Processing (NLP)
By Delivery Mode
- On-Device AI Cloud-based AI Hybrid AI
By Application
- Hypertension Management Remote Patient Monitoring Cardiovascular Disease Prediction Fitness and Wellness Others
By End-Use
- Hospitals & Acute Care Home Care Settings/Patient (Consumers) Clinics & Ambulatory Care Others
By Region
- North America
- U.S. Canada
- UK Germany France Italy Spain Denmark Sweden Norway
- Japan China India South Korea Australia Thailand
- Brazil Mexico Argentina
- South Africa Saudi Arabia UAE Kuwait
Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard:About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research You can place an order or ask any questions, please feel free to contact us at ...Europe Region: +44 778 256 0738
North America Region: +1 8044 4193 44
APAC Region: +91 9356 9282 04
Web:Our Trusted Data Partners
Precedence Research | Towards Packaging | Towards Food and Beverages | Towards Chemical and Materials | Towards Dental | Towards EV Solutions | Healthcare Webwire Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | PinterestAlso Read:
/insights/continuous-blood-pressure-monitoring-devices-market-sizing
/insights/blood-bank-market-sizing
/insights/blood-based-biomarkers-market
/insights/non-invasive-blood-glucose-monitoring-system-market
/insights/sterile-disposable-vacuum-blood-collection-tube-market-sizing
/insights/cryopreservation-bags-and-freezing-bags-market-sizing
/insights/automated-blood-processing-equipment-market-sizing
/insights/liquid-biopsy-ivd-market-sizing
/insights/blood-product-market-sizing
/insights/blood-plasma-fractionation-market-sizing
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment